Literature DB >> 8829651

Heteroplasmy levels of a mitochondrial gene mutation associated with diabetes mellitus decrease in leucocyte DNA upon aging.

L M 't Hart1, J J Jansen, H H Lemkes, P de Knijff, J A Maassen.   

Abstract

We showed previously that a mutation in the mitochondrial tRNALeu(UUR) gene at position 3243 associates with maternally inherited diabetes and deafness (MIDD). This mutation shows heteroplasmy in DNA from peripheral blood and other tissues. To examine whether heteroplasmy levels in peripheral blood DNA change upon aging, heteroplasmy levels were determined in DNA samples from peripheral blood, collected recently and 1.5-6 years ago, from 18 individuals carrying the 3243 mutation. It was found that 17 out of 18 carriers showed a decrease upon aging (P = 0.001), the average change being -0.69 +/- 0.61% per year. These data indicate a continuous selection against haematopoietic (precursor) cells carrying high levels of the 3243 mutation. Moreover, they imply that heteroplasmy levels may decrease below the detection limit if DNA from peripheral blood is analyzed from elderly individuals. DNA from oral mucosa cells was found to be a good alternative as heteroplasmy levels for the 3243 mutation are on the average 1.7 fold higher than in DNA from peripheral blood.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8829651     DOI: 10.1002/(SICI)1098-1004(1996)7:3<193::AID-HUMU2>3.0.CO;2-C

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  18 in total

1.  Heterogeneous tissue distribution of a mitochondrial DNA polymorphism in heteroplasmic subjects without mitochondrial disorders.

Authors:  E Kirches; M Michael; M Warich-Kirches; T Schneider; S Weis; G Krause; C Mawrin; K Dietzmann
Journal:  J Med Genet       Date:  2001-05       Impact factor: 6.318

Review 2.  Mitochondria.

Authors:  P F Chinnery; E A Schon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

3.  Depletion of mitochondrial DNA in leucocytes harbouring the 3243A->G mtDNA mutation.

Authors:  Angela Pyle; Robert W Taylor; Steve E Durham; Marcus Deschauer; Andrew M Schaefer; David C Samuels; Patrick F Chinnery
Journal:  J Med Genet       Date:  2006-09-01       Impact factor: 6.318

4.  Tissue specific distribution of the 3243A->G mtDNA mutation.

Authors:  A L Frederiksen; P H Andersen; K O Kyvik; T D Jeppesen; J Vissing; M Schwartz
Journal:  J Med Genet       Date:  2006-02-20       Impact factor: 6.318

5.  Rapid and sensitive real-time polymerase chain reaction method for detection and quantification of 3243A>G mitochondrial point mutation.

Authors:  Rinki Singh; Sian Ellard; Andrew Hattersley; Lorna W Harries
Journal:  J Mol Diagn       Date:  2006-05       Impact factor: 5.568

Review 6.  Maternally inherited diabetes and deafness: a new diabetes subtype.

Authors:  J A Maassen; T Kadowaki
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

Review 7.  Mitochondrial diabetes mellitus.

Authors:  J A Maassen; G M C Janssen; H H J P Lemkes
Journal:  J Endocrinol Invest       Date:  2002-05       Impact factor: 4.256

8.  Presence of mitochondrial tRNA(Leu(UUR)) A to G 3243 mutation in DNA extracted from serum and plasma of patients with type 2 diabetes mellitus.

Authors:  S Zhong; M C Ng; Y M Lo; J C Chan; P J Johnson
Journal:  J Clin Pathol       Date:  2000-06       Impact factor: 3.411

9.  Audiologic and genetic features of the A3243G mtDNA mutation.

Authors:  Richard J Vivero; Xiaomei Ouyang; Yeunjung Grant Kim; Wendy Liu; Lilin Du; Denise Yan; Xue Zhong Liu
Journal:  Genet Test Mol Biomarkers       Date:  2013-03-11

10.  Frequency of MELAS main mutation in a phenotype-targeted young ischemic stroke patient population.

Authors:  Turgut Tatlisumak; Jukka Putaala; Markus Innilä; Christian Enzinger; Tiina M Metso; Sami Curtze; Bettina von Sarnowski; Alexandre Amaral-Silva; Gerhard Jan Jungehulsing; Christian Tanislav; Vincent Thijs; Arndt Rolfs; Bo Norrving; Franz Fazekas; Anu Suomalainen; Edwin H Kolodny
Journal:  J Neurol       Date:  2015-11-14       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.